A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A macOS ClickFix campaign shifted tactics from openly serving infostealer lures to hiding them behind a browser-fingerprinting gate. The change makes malicious infrastructure harder to detect while ...

Recursion Pharmaceuticals recently reported mixed Q2 results, revealing a $7.67 million revenue decline and an adjusted loss of $0.25 per share. Despite these challenges, the company achieved ...